PharmCorp RX Announces C$10M Bought-Deal Offering

PharmCorp RX has entered into a bought-deal agreement to raise C$10 million by issuing 19.6 million units at C$0.51 each, with Acumen Capital Finance Partners and Canaccord Genuity co-leading the underwriting syndicate.

By Preeti Singh, SA News Editor · Seeking Alpha · July 7, 2026, 11:52 UTC

PharmCorp RX Announces C$10M Bought-Deal Offering

Topics: bought-deal agreement capital raise underwriting syndicate

Read the full article at Seeking Alpha

More World news

Nvidia CEO Jensen Huang Ousted Amid Allegations of Personal Misconduct and National Security Concerns TechCrunch · November 12, 2026, 16:32 UTC
Pomerantz Law Firm Investigates Silvercorp Metals Inc. Following Production Shortfalls and Revenue Decline PR Newswire · November 12, 2026, 16:30 UTC
Cold Spring Harbor Laboratory Raises $6.5 Million at 21st Annual Double Helix Medals Dinner PR Newswire · November 12, 2026, 16:30 UTC
Deloitte Recognized as Leader in IDC MarketScape Worldwide Digital Identity Services Assessment PR Newswire · November 12, 2026, 16:30 UTC
SpaceX Announces $74 Billion Investment in AI Data Center Projects in Texas and Arizona Seeking Alpha · November 12, 2026, 16:25 UTC
Ofcom Fines Meta £450,000 Over Inaccurate WhatsApp Business Data Seeking Alpha · November 12, 2026, 16:25 UTC
USPS Seeks 11% Fuel Surcharge for Domestic Priority Mail and Package Deliveries CNBC · November 12, 2026, 16:17 UTC
Joe Lavis Named to D CEO's 2027 Dallas 500 List PR Newswire · November 12, 2026, 16:26 UTC
Sanmina Corporation (SANM) Shares Rise 8% Amid Five-Day Winning Streak Seeking Alpha · November 12, 2026, 16:23 UTC
Nvidia CEO Jensen Huang Resigns Amid Personal Scandal and National Security Concerns Motley Fool · November 12, 2026, 16:17 UTC